Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Mariah Williams

Physician Assistant Columbus, GA Physician Assistant

NPI 1982173167 CMS profile 10609407

7830 Veterans Pkwy Ste H, Columbus, GA 31909

Open in the dashboard

General payments

$3,809

232 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Mariah Williams of Columbus, GA is reported in the CMS Open Payments database as having received $3,809 across 232 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $47 3
2023 General $32 2
2022 General $1,280 80
2021 General $2,450 147

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mariah Williams
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Mariah Williams were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Mariah Williams Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,450 $132 $37–$438 $132
2022 $1,280 $155 $48–$522 $149
2023 $32 $167 $52–$557 $160
2024 $47 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. AbbVie, Inc. $831 57 payments
  2. Novo Nordisk Inc $734 49 payments
  3. Esperion Therapeutics, Inc. $539 22 payments
  4. Lilly USA, LLC $314 25 payments
  5. AstraZeneca Pharmaceuticals LP $214 14 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $208 12 payments
  7. Eisai Inc. $200 8 payments
  8. Amarin Pharma Inc. $172 11 payments
  9. Biohaven Pharmaceuticals, Inc. $97 4 payments
  10. Biohaven Pharmaceutical Holding Company Ltd. $85 5 payments
  11. Other $416 25 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $3,809 232 payments
Products named General payments · program years 2021–2024
  1. NEXLETOL $539 22 payments
  2. VRAYLAR $439 30 payments
  3. Ozempic $428 33 payments
  4. RYBELSUS $411 32 payments
  5. NEXLIZET $249 2 payments
  6. UBRELVY $226 15 payments
  7. FARXIGA $214 14 payments
  8. Kerendia $208 12 payments
  9. Dayvigo $200 8 payments
  10. Wegovy $198 8 payments
  11. Other $1,679 113 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

232 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record